Welcome to LookChem.com Sign In|Join Free
The company logo of Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)

Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)

Free supplier Enterprise Certification

Free
supplier
10th
years

Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)

Business Type:Trading Company

Audited Supplier

Main Products:
Year Established:
2014
Home>>Products>>Afatinib

Product Certification&
Enterprise Certification

More Detail

Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)

Country: China (Mainland)

Business Type:Trading Company

Afatinib

CAS NO.850140-72-6

  • Min.Order: 0 Metric Ton
  • Payment Terms:
Contact Supplier

Product Details

Keywords

  • (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dim
  • Tovok
  • BIBW 2992

Quick Details

  • ProName: Afatinib
  • CasNo: 850140-72-6
  • Appearance: white crystalline powder
  • Application: API
  • DeliveryTime: delivery after confirming an order
  • PackAge: aluminium foil bag; drum; as per your ...
  • ProductionCapacity: Metric Ton/Day
  • Purity: 99%
  • Storage: store in cool place. Keep container ti...
  • Transportation: air transport, sea transport
  • LimitNum: 0 Metric Ton

Superiority

Details

 

 

Trading information  

 

 

Product NameAfatinib                                                          
CAS No.850140-72-6
Molecular Formula C24H25ClFN5O3
Molecular Weight485.94
Appearancewhite powder
Purity99.0%
Package

aluminium foil bag; drum

Payment TermsL/C; D/A; D/P; T/T
Deliveryby air; by ship

 

 

 

Sample Service

 

Considering the various needs of buyers, we provide small quantity sample to customers. You are welcomed to contact us for the detailed specifications of our APIs and pharmaceutical intermediates. Customers are also expected to confirm the type of freight transport and  payment. Any more question please contact us directly.

 

 

 

 

Mechanism of action for Afatinib

 

Afatinib is an irreversible kinase inhibitor and binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) to inhibit tyrosine kinase autophosphorylation. This results in a downregulation of ErbB signalling and subsequent inhibition of proliferation of cell lines expressing wild-type EGFR, selected EGFR exon 19 deletion mutations, or exon 21 L858R mutations. It also inhibited in vitro proliferation of cell lines overexpressing HER2. Overall, tumour growth was inhibited. 

 

Mechanism of action for Afatinib

 

 

Technical Team

 

Jiangsu Allyrise Pharmaceutical Co., Ltd have a young and innovative technician team with average age of 29 and backgrounds of famous universerties. We have rich experience in lab research and pilot scale experiment, laying the foundation for further personnel cultivation.

 

 Allyrise lab

  

 

Research and Development

 

Relying on advanced research platform and relative service of China Medicine City, Allyrise have made achievements in areas of antineoplastic, antiviral, diabetes drugs in recent years, with more than 20 kinds of APIs and advanced intermediates magnified in pilotscale experiment. The products are widely sold to famous pharmaceutical companies from around the world. To enhance our research and development level, Allyrise developed close cooperation with foreign pharmaceutical companies in customer synthesis and developing new drugs.

 

 

 

 

 


 

Hot Product